Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record history shows the site revision updated to v3.6.6 (replacing v3.6.5). This reflects a software release rather than any modification to the trial data or records.SummaryDifference0.1%

- Check25 days agoChange DetectedIntroduction of a new 'Study Status' item in the history and a new version entry (version 21) dated 2026-07-24. An older entry dated 2026-05-12 was removed.SummaryDifference0.3%

- Check39 days agoChange DetectedThe study record history now includes a new revision v3.6.5 and removes the previous revision v3.6.4, indicating an update to the record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe History section now shows revision v3.6.4, replacing v3.6.3. This indicates a new version of the record/history was published, updating the page's underlying revision metadata.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision label in the history table updates from v3.6.2 to v3.6.3, indicating a new revision of the study record.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page history now lists Revision: v3.6.2, replacing v3.6.0. This reflects a small update to the page’s versioning rather than a change to the study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.